Fig. 4
From: The chromatin guardian ATRX is a strong prognostic biomarker in melanoma
Whole-genome sequencing analysis of 70 melanoma metastases (A). No significant correlation between ATRX copy number variation and ATRX protein expression (B–E).
Fig. 4 | Scientific Reports
